As of 1:44pm ET
| +0.65 / +20.70%|
The 1 analysts offering 12-month price forecasts for Imprimis Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +31.93% increase from the last price of 3.79.
The current consensus among 1 polled investment analysts is to Buy stock in Imprimis Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.